Search for: "Akzo Nobel N.V." Results 1 - 6 of 6
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Mar 2007, 9:42 pm
By Donald Zuhn --- Schering-Plough Corporation announced on March 12th that its Board of Directors has approved the purchase of Organon BioSciences N.V. from Akzo Nobel N.V. for US $14.4 billion. [read post]
16 Sep 2010, 8:36 am by Kara OBrien
  Gibson Dunn partners Daniel Swanson, David Wood, and James Ashe-Taylor will be joined by Jasper de Gou, Senior Competition Counsel of Akzo Nobel N.V. [read post]
20 Apr 2010, 5:07 pm by Dr. Shezad Malik
., Akzo Nobel NV, Organon Biosciences, N.V., and Schering-Plough Corporation, not only knew about the potential side effects associated with NUVARING®, but concealed those risks from the public, including the FDA during the approval process. [read post]
19 Jan 2008, 1:05 am
The FTC had announced a complaint last November challenging Schering Plough's proposed acquisition of healthcare products company Organon BioSciences for $14.4 billion from Dutch company Akzo-Nobel N.V. because the deal would allegedly harm competition in U.S. markets for the sale of three poultry vaccine in violation of the FTC Act § 5 and the Clayton Act § 7. [read post]
13 Dec 2018, 8:51 am by Maria Kennedy (UK)
However, in 2014 the Court of Appeal did provide an insight into the potential scope of the jurisdiction of section 7 through its interpretation of what “carrying on business in the UK”[3] means in the context of an appeal from a decision of the Competition Appeal Tribunal.[4] In Akzo Nobel N.V. v Competition Commission & ors, the Court held that it is not necessary for a company to have a physical presence or fixed place of business in the UK to be found… [read post]
16 Feb 2012, 5:01 pm by Oliver G. Randl
You might have heard that there has been another referral to the Enlarged Board of appeal (EBA). [read post]